Mirum Pharmaceuticals (MIRM) Earnings Analysis
Mirum Pharmaceuticals (MIRM) next reports earnings on 2026-07-30, consensus EPS -0.72792 USD. Last quarter (2025-02-26) it missed with EPS -0.49 USD vs -0.27 USD est (-81.5%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E -8.41.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does MIRM next report earnings?
| Next earnings date | 2026-07-30 |
|---|---|
| Consensus EPS estimate | -0.72792 USD |
| Revenue estimate | 0.17B |
MIRM earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-02-26 | -0.49 USD | -0.27 USD | -81.5% | Miss |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
MIRM valuation and analyst view
| Trailing P/E | -8.41 |
|---|---|
| Trailing EPS | -13.57395 USD |
| Price / book | 27.78 |
| Dividend yield | 0.00% |
| Market cap | 5.75B |
| Analyst consensus | Buy (18 buy / 0 hold / 0 sell) |
| Avg price target | 147.21 USD |
Related research pages
Frequently asked questions
When is Mirum Pharmaceuticals (MIRM)'s next earnings date?
Mirum Pharmaceuticals is next scheduled to report on 2026-07-30, with a consensus EPS estimate of -0.72792 USD and revenue estimate of 0.17B.
Did MIRM beat earnings last quarter?
In its 2025-02-26 report, MIRM posted EPS of -0.49 USD versus a -0.27 USD estimate — a miss of 81.5%.
What is MIRM's earnings track record?
Over the last 1 reported quarters with consensus data, MIRM beat estimates 0 times (0%).
What is MIRM's current P/E ratio and EPS?
MIRM trades at a trailing P/E of -8.41 on trailing EPS of -13.573953117992634 USD.
What do analysts rate MIRM?
Analyst consensus is "Buy" across 18 ratings (1 strong buy, 17 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 147.21 USD.